These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12759480

  • 1. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema.
    Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE, National Emphysema Treatment Trial Research Group.
    N Engl J Med; 2003 May 22; 348(21):2092-102. PubMed ID: 12759480
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. National Emphysema Treatment Trial redux: accentuating the positive.
    Sanchez PG, Kucharczuk JC, Su S, Kaiser LR, Cooper JD.
    J Thorac Cardiovasc Surg; 2010 Sep 22; 140(3):564-72. PubMed ID: 20723727
    [Abstract] [Full Text] [Related]

  • 4. The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.
    Blough DK, Ramsey S, Sullivan SD, Yusen R, Nett Research Group.
    Health Econ; 2009 Jan 22; 18(1):91-101. PubMed ID: 18435426
    [Abstract] [Full Text] [Related]

  • 5. Is lung volume reduction surgery effective in the treatment of advanced emphysema?
    Zahid I, Sharif S, Routledge T, Scarci M.
    Interact Cardiovasc Thorac Surg; 2011 Mar 22; 12(3):480-6. PubMed ID: 21131683
    [Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
    Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2311-21. PubMed ID: 16360064
    [Abstract] [Full Text] [Related]

  • 7. A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.
    Ramsey SD, Blough DK, Sullivan SD.
    Med Care; 2008 May 20; 46(5):542-8. PubMed ID: 18438203
    [Abstract] [Full Text] [Related]

  • 8. Updated evaluation of the cost-effectiveness of lung volume reduction surgery.
    Ramsey SD, Shroyer AL, Sullivan SD, Wood DE.
    Chest; 2007 Mar 20; 131(3):823-832. PubMed ID: 17356099
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ, Bakhai A, Shi C, Githiora L, Lavelle T, Berezin RH, Leon MB, Moses JW, Carrozza JP, Zidar JP, Kuntz RE, SIRIUS Investigators.
    Circulation; 2004 Aug 03; 110(5):508-14. PubMed ID: 15262844
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion.
    Meyers BF, Yusen RD, Guthrie TJ, Patterson GA, Lefrak SS, Davis GE, Cooper JD.
    J Thorac Cardiovasc Surg; 2004 Mar 03; 127(3):829-35. PubMed ID: 15001913
    [Abstract] [Full Text] [Related]

  • 14. [Four-year results after lung volume reduction surgery for emphysema].
    Juan Samper G, Ramón Capilla M, Cantó Armengol A, Martínez Pérez ML, Lloret Pérez T, Rubio Gomis E, Marín Pardo J.
    Arch Bronconeumol; 2004 Oct 03; 40(10):443-8. PubMed ID: 15491535
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema.
    Weder W, Tutic M, Lardinois D, Jungraithmayr W, Hillinger S, Russi EW, Bloch KE.
    Ann Thorac Surg; 2009 Jan 03; 87(1):229-36; discussion 236-7. PubMed ID: 19101303
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.
    Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW.
    J Thorac Cardiovasc Surg; 2004 May 03; 127(5):1366-72. PubMed ID: 15115994
    [Abstract] [Full Text] [Related]

  • 18. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):761-9. PubMed ID: 16139122
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction.
    Rinfret S, Cohen DJ, Lamas GA, Fleischmann KE, Weinstein MC, Orav J, Schron E, Lee KL, Goldman L.
    Circulation; 2005 Jan 18; 111(2):165-72. PubMed ID: 15630030
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.